RNA Template Replication Using T7 Polymerase Without DNA Intermediates

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for improved methods of producing RNA for various applications such as RNAi therapeutics, diagnostic probes, RNA sequencing, directed evolution of RNA aptamers, and RNA vaccines without intermediate conversion to DNA.

Innovation Solution

The method involves replicating RNA using transcription polymerases in a reaction mixture containing ribonucleoside triphosphates and specific RNA templates with 2-way and 4-way repeat configurations, which can be performed in the absence of DNA, and optionally using a DNA seed to generate the RNA template.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional RNA production methods are used, then RNA can be produced, but the process requires intermediate conversion to DNA which increases process complexity and time

Engineering Contradiction:
ImproveRNA production efficiencyVSAvoidprocess complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention extracts and eliminates the unnecessary DNA intermediate step from the traditional RNA production process. By using transcription polymerases that can directly replicate RNA templates, the method removes the DNA conversion step entirely, thereby reducing process complexity while maintaining or improving productivity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Instead of following the conventional DNA→RNA transcription pathway, the invention inverts the approach by using RNA→RNA replication. This inversion allows direct RNA amplification without requiring DNA intermediates, simplifying the overall process and reducing the number of steps involved.

Inventive Principle:
Principle #13The other way round (Inversion)

2Reliability

If RNA templates without specific structures are used, then replication may occur, but the fidelity and diversity of replicated RNA populations are reduced

Engineering Contradiction:
Improvereplication fidelityVSAvoidRNA population diversity
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention applies local quality by introducing specific structural features (inverted repeats forming hairpin structures) at particular locations within the RNA template. These localized structural elements at the ends of the RNA molecule enhance replication fidelity and enable population diversity without requiring changes to the entire RNA sequence.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention changes the structural parameters of the RNA template by incorporating specific inverted repeat sequences that form hairpin structures. This parameter change in the template's secondary structure enables the transcription polymerase to maintain high fidelity while generating diverse RNA populations through controlled replication.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for efficient amplification of RNA, enabling its use in RNAi therapeutics, diagnostic probes, RNA sequencing, directed evolution of RNA aptamers, and RNA vaccines without the need for intermediate DNA conversion.

Implementation Method 1

transcription polymerases mediate information transfer from DNA to RNA across the tree of life

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS12612658B2RNA replication using transcription polymerases
Publication Date: 2026.04.28 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US12612658B2 patent drawing
  • US12612658B2 patent drawing
  • US12612658B2 patent drawing

AI summary

Compositions and methods for amplifying RNA by replication using transcription polymerases are disclosed. Such replicated RNAs can be used in various applications such as RNAi therapeutics, diagnostic probes, RNA sequencing, directed evolution of RNA aptamers without intermediate conversion to DNA, and RNA vaccines. The transcription polymerases comprise T7 bacteriophage RNA polymerase.